Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Pharmacol Res. 2008 Jun 24;58(2):88–111. doi: 10.1016/j.phrs.2008.06.007

Figure 2. The role of the chemokines in cardiac injury.

Figure 2

Both CC and CXC chemokines are induced in the infarcted myocardium. CXC chemokines that contain the ELR motif (such as IL-8) induce neutrophil infiltration and may exert angiogenic effects. In contrast, ELR-negative CXC chemokines (such as IP-10) have angiostatic and antifibrotic properties. Early IP-10 upregulation in the infarcted heart may inhibit granulation tissue formation until the wound is debrided from dead cells and a provisional matrix necessary to support fibroblast and endothelial cell migration is formed. In addition, IP-10 may play a role in recruitment of effector T cells. On the other hand, the CXC chemokine SDF-1 may induce infiltration of CXCR4+ progenitor cells enhancing tissue regeneration and angiogenesis. The best studied CC chemokine is MCP-1, a potent mononuclear cell chemoattractant with angiogenic and pro-fibrotic properties. MCP-1 deficiency is associated with attenuated adverse remodeling at the expense of delayed clearance of the infarct from dead cardiomyocytes. MCP-3, MIP-1α and MIP-1β are also induced in the infarct; however, their role in cardiac injury and repair remains unknown (Symbols: PC, immature progenitor cells; N, neutrophils; Mo, monocytes; L, lymphocytes; EC, endothelial cells; F, fibroblasts).